- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Minerva Neurosciences Inc (NERV)
Minerva Neurosciences Inc stock price live, this page displays NASDAQ NERV stock exchange data. View the NERV premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Minerva Neurosciences Inc real time stock price chart below.
What Is the Minerva Neurosciences Inc Stock Price Today?
The Minerva Neurosciences Inc stock price today is 4.270.
What Is the Stock Symbol for Minerva Neurosciences Inc?
The stock symbol for Minerva Neurosciences Inc is "NERV."
What Stock Exchange Does Minerva Neurosciences Inc Trade On?
Minerva Neurosciences Inc is listed and trades on the NASDAQ stock exchange.
Is Minerva Neurosciences Inc a Good Stock to Buy?
Determining whether Minerva Neurosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NERV quote. (ISIN: US6033802058)
What Is the Minerva Neurosciences Inc Stock Price Today?
The Minerva Neurosciences Inc stock price today is 4.270.
What Is the Stock Symbol for Minerva Neurosciences Inc?
The stock symbol for Minerva Neurosciences Inc is "NERV."
What Stock Exchange Does Minerva Neurosciences Inc Trade On?
Minerva Neurosciences Inc is listed and trades on the NASDAQ stock exchange.
Is Minerva Neurosciences Inc a Good Stock to Buy?
Determining whether Minerva Neurosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NERV quote. (ISIN: US6033802058)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.010
4.405
52 wk Range
1.760
12.460
NERV is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.0104.405
52 wk Range
1.76012.460
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
NERV Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Neutral
Price Target
9.500
Upside
+122.48%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
- Form 424B5 Minerva Neurosciences Inc For: 27 May
- Investing.com
- Minerva Neu receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Form 13G MINERVA NEUROSCIENCES For: 15 May
- Investing.com
- Form 424B5 Minerva Neurosciences Inc For: 27 May
- Investing.com
- Form 13G MINERVA NEUROSCIENCES For: 15 May
- Investing.com
- Form 10Q Minerva Neurosciences Inc For: 5 May
- Investing.com
- Form DEF 14A Minerva Neurosciences Inc For: 23 April
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Strong Sell
Analyst Ratings
1 Buy
2 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 9.500
(+122.48% Upside)
Earnings
Latest Release
May 05, 2026
EPS / Forecast
-0.17 / -0.13
Revenue / Forecast
-- / --
Compare NERV to Peers and Sector
Metrics to compare | NERV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNERVPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.5x | −6.4x | −0.4x | |
PEG Ratio | 0.00 | −0.04 | 0.00 | |
Price/Book | −0.8x | 2.1x | 2.6x | |
Price / LTM Sales | - | 16.7x | 3.0x | |
Upside (Analyst Target) | 75.6% | 141.7% | 50.8% | |
Fair Value Upside | Unlock | 6.7% | 9.4% | Unlock |
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone, which is in Phase 3 confirmatory trial for the treatment of negative symptoms in patients with schizophrenia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Minerva Neurosciences (NERV) Stock Price Today?
The Minerva Neurosciences stock price today is 4.270 USD.
What Stock Exchange Does Minerva Neurosciences Trade On?
Minerva Neurosciences is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Minerva Neurosciences?
The stock symbol for Minerva Neurosciences is "NERV."
What Is the Minerva Neurosciences Market Cap?
As of today, Minerva Neurosciences market cap is 198.930M USD.
What Is Minerva Neurosciences's Earnings Per Share (TTM)?
The Minerva Neurosciences EPS (TTM) is -23.656.
When Is the Next Minerva Neurosciences Earnings Date?
Minerva Neurosciences will release its next earnings report on Aug 04, 2026.
From a Technical Analysis Perspective, Is NERV a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Minerva Neurosciences Stock Split?
Minerva Neurosciences has split 1 times.
How Many Employees Does Minerva Neurosciences Have?
Minerva Neurosciences has 7 employees.
What is the current trading status of Minerva Neurosciences (NERV)?
As of Jul 19, 2026, Minerva Neurosciences (NERV) is trading at a price of 4.270 USD, with a previous close of 4.210 USD. The stock has fluctuated within a day range of 4.010 USD to 4.405 USD, while its 52-week range spans from 1.760 USD to 12.460 USD.
What Is Minerva Neurosciences (NERV) Price Target According to Analysts?
The average 12-month price target for Minerva Neurosciences is 9.500 USD, with a high estimate of 14 USD and a low estimate of 7 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an +122.48% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.